Ascendis Pharma Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
| Owner Type | Number of Shares | Ownership Percentage |
|---|---|---|
| Private Companies | 13,541 | 0.0216% |
| Individual Insiders | 443,142 | 0.706% |
| Hedge Funds | 3,755,555 | 5.98% |
| VC/PE Firms | 10,107,400 | 16.1% |
| Institutions | 48,448,243 | 77.2% |
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
| Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
|---|---|---|---|---|---|---|
| 10,107,400 | US$1.4b | -5.71% | 19.04% | |||
| 5,749,227 | US$795.9m | -4.11% | 0.64% | |||
| 5,434,780 | US$752.4m | -3.34% | 0.07% | |||
| 5,114,143 | US$708.0m | -0.43% | 0.05% | |||
| 4,030,634 | US$558.0m | 6.01% | 3.01% | |||
| 3,994,785 | US$553.0m | 3.64% | 0.24% | |||
| 3,755,555 | US$519.9m | 2.33% | 7.51% | |||
| 3,248,293 | US$449.7m | -0.88% | 0.07% | |||
| 2,181,268 | US$302.0m | 0.59% | 0.02% | |||
| 1,519,219 | US$210.3m | 20.1% | 0.04% | |||
| 1,058,937 | US$146.6m | -12.3% | 0.05% | |||
| 906,747 | US$125.5m | 35.1% | 0.03% | |||
| 792,945 | US$109.8m | -5.92% | 1.44% | |||
| 754,032 | US$104.4m | 0% | 7.94% | |||
| 725,651 | US$100.5m | -6.05% | 0.11% | |||
| 684,072 | US$94.7m | 35.2% | 0.12% | |||
| 625,000 | US$86.5m | 0% | 9.51% | |||
| 589,667 | US$81.6m | 0% | 4.83% | |||
| 588,936 | US$81.5m | -2.31% | 0.03% | |||
| 539,948 | US$74.8m | -12.2% | 4.85% | |||
| 423,279 | US$58.6m | 28.8% | no data | |||
| 422,854 | US$58.5m | 3.14% | 0.03% | |||
| 372,414 | US$51.6m | 3.15% | 0.03% | |||
| 361,830 | US$50.1m | -8.73% | 0.06% | |||
| 361,029 | US$50.0m | 0% | 0.03% |